COMPAGNIE CHARGEURS INVEST (CRI.PA) Fundamental Analysis & Valuation

EPA:CRI • FR0000130692

Current stock price

8.66 EUR
+0.16 (+1.88%)
Last:

This CRI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CRI.PA Profitability Analysis

1.1 Basic Checks

  • CRI had negative earnings in the past year.
  • In the past year CRI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CRI reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
CRI.PA Yearly Net Income VS EBIT VS OCF VS FCFCRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

  • With a Return On Assets value of -2.49%, CRI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -9.87%, CRI is doing worse than 66.67% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 0.26%, CRI is doing worse than 66.67% of the companies in the same industry.
  • CRI had an Average Return On Invested Capital over the past 3 years of 2.15%. This is below the industry average of 6.58%.
Industry RankSector Rank
ROA -2.49%
ROE -9.87%
ROIC 0.26%
ROA(3y)-0.61%
ROA(5y)0.79%
ROE(3y)-2.6%
ROE(5y)2.31%
ROIC(3y)2.15%
ROIC(5y)3.55%
CRI.PA Yearly ROA, ROE, ROICCRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

  • With a Operating Margin value of 0.64%, CRI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of CRI has declined.
  • Looking at the Gross Margin, with a value of 29.62%, CRI is doing worse than 73.33% of the companies in the same industry.
  • CRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.64%
PM (TTM) N/A
GM 29.62%
OM growth 3Y-54%
OM growth 5Y-40.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.99%
GM growth 5Y2.14%
CRI.PA Yearly Profit, Operating, Gross MarginsCRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CRI.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRI is destroying value.
  • The number of shares outstanding for CRI remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CRI has more shares outstanding
  • CRI has a worse debt/assets ratio than last year.
CRI.PA Yearly Shares OutstandingCRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
CRI.PA Yearly Total Debt VS Total AssetsCRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 0.98, we must say that CRI is in the distress zone and has some risk of bankruptcy.
  • CRI's Altman-Z score of 0.98 is on the low side compared to the rest of the industry. CRI is outperformed by 73.33% of its industry peers.
  • CRI has a Debt/Equity ratio of 1.56. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CRI (1.56) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACC0.04
WACC5.91%
CRI.PA Yearly LT Debt VS Equity VS FCFCRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.42 indicates that CRI has no problem at all paying its short term obligations.
  • CRI has a better Current ratio (2.42) than 93.33% of its industry peers.
  • CRI has a Quick Ratio of 2.07. This indicates that CRI is financially healthy and has no problem in meeting its short term obligations.
  • CRI's Quick ratio of 2.07 is amongst the best of the industry. CRI outperforms 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2.07
CRI.PA Yearly Current Assets VS Current LiabilitesCRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CRI.PA Growth Analysis

3.1 Past

  • The earnings per share for CRI have decreased strongly by -431.47% in the last year.
  • CRI shows a decrease in Revenue. In the last year, the revenue decreased by -2.94%.
  • CRI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.58% yearly.
EPS 1Y (TTM)-431.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.73%
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y-17%
Revenue growth 5Y-12.58%
Sales Q2Q%-18.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.89% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -13.13% on average over the next years. This is quite bad
EPS Next Y175.41%
EPS Next 2Y44.29%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue Next Year-24.7%
Revenue Next 2Y-11.26%
Revenue Next 3Y-13.13%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRI.PA Yearly Revenue VS EstimatesCRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
CRI.PA Yearly EPS VS EstimatesCRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. CRI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CRI. In the last year negative earnings were reported.
  • CRI is valuated reasonably with a Price/Forward Earnings ratio of 10.21.
  • Based on the Price/Forward Earnings ratio, CRI is valued cheaper than 93.33% of the companies in the same industry.
  • CRI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.68.
Industry RankSector Rank
PE N/A
Fwd PE 10.21
CRI.PA Price Earnings VS Forward Price EarningsCRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • 60.00% of the companies in the same industry are cheaper than CRI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.8
CRI.PA Per share dataCRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CRI's earnings are expected to grow with 23.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.29%
EPS Next 3Y23.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. CRI.PA Dividend Analysis

5.1 Amount

  • CRI has a Yearly Dividend Yield of 1.53%.
  • Compared to an average industry Dividend Yield of 3.01, CRI is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, CRI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

  • The dividend of CRI decreases each year by -14.15%.
Dividend Growth(5Y)-14.15%
Div Incr Years1
Div Non Decr Years1
CRI.PA Yearly Dividends per shareCRI.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CRI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-12.08%
EPS Next 2Y44.29%
EPS Next 3Y23.89%
CRI.PA Yearly Income VS Free CF VS DividendCRI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

More info and screens

Find the best dividend stocksShow peers with best dividend

CRI.PA Fundamentals: All Metrics, Ratios and Statistics

COMPAGNIE CHARGEURS INVEST

EPA:CRI (4/29/2026, 7:00:00 PM)

8.66

+0.16 (+1.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Industry Strength17.57
Industry Growth16
Earnings (Last)03-19
Earnings (Next)N/A
Inst Owners4.65%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap215.55M
Revenue(TTM)419.70M
Net Income(TTM)-24.00M
Analysts74.29
Price Target12.07 (39.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly Dividend0.12
Dividend Growth(5Y)-14.15%
DP-12.08%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.74%
PT rev (3m)4.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.66%
EPS NY rev (3m)11.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-28.85%
Revenue NY rev (3m)-31.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.21
P/S 0.51
P/FCF N/A
P/OCF 9.98
P/B 0.89
P/tB 11.65
EV/EBITDA 17.8
EPS(TTM)-0.99
EYN/A
EPS(NY)0.85
Fwd EY9.8%
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)0.87
OCFY10.02%
SpS16.86
BVpS9.77
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -9.87%
ROCE 0.36%
ROIC 0.26%
ROICexc 0.31%
ROICexgc 0.48%
OM 0.64%
PM (TTM) N/A
GM 29.62%
FCFM N/A
ROA(3y)-0.61%
ROA(5y)0.79%
ROE(3y)-2.6%
ROE(5y)2.31%
ROIC(3y)2.15%
ROIC(5y)3.55%
ROICexc(3y)2.55%
ROICexc(5y)4.64%
ROICexgc(3y)5.43%
ROICexgc(5y)10.56%
ROCE(3y)2.94%
ROCE(5y)4.87%
ROICexgc growth 3Y-70.67%
ROICexgc growth 5Y-55.68%
ROICexc growth 3Y-65.68%
ROICexc growth 5Y-52.17%
OM growth 3Y-54%
OM growth 5Y-40.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.99%
GM growth 5Y2.14%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF N/A
Debt/EBITDA 12.39
Cap/Depr 112.9%
Cap/Sales 7.51%
Interest Coverage 250
Cash Conversion 70.59%
Profit Quality N/A
Current Ratio 2.42
Quick Ratio 2.07
Altman-Z 0.98
F-Score5
WACC5.91%
ROIC/WACC0.04
Cap/Depr(3y)84.29%
Cap/Depr(5y)67.14%
Cap/Sales(3y)5.02%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-431.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.73%
EPS Next Y175.41%
EPS Next 2Y44.29%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y-17%
Revenue growth 5Y-12.58%
Sales Q2Q%-18.24%
Revenue Next Year-24.7%
Revenue Next 2Y-11.26%
Revenue Next 3Y-13.13%
Revenue Next 5YN/A
EBIT growth 1Y-91.48%
EBIT growth 3Y-61.82%
EBIT growth 5Y-47.75%
EBIT Next Year38.24%
EBIT Next 3Y5.57%
EBIT Next 5YN/A
FCF growth 1Y-134.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.46%
OCF growth 3YN/A
OCF growth 5Y-21.62%

COMPAGNIE CHARGEURS INVEST / CRI.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRI.PA.


What is the valuation status for CRI stock?

ChartMill assigns a valuation rating of 4 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Fairly Valued.


How profitable is COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for COMPAGNIE CHARGEURS INVEST?

The Earnings per Share (EPS) of COMPAGNIE CHARGEURS INVEST (CRI.PA) is expected to grow by 175.41% in the next year.